Plasma IP-10 could identify early lung disease in severe COVID-19 patients

Ann Acad Med Singap. 2021 Nov;50(11):856-858. doi: 10.47102/annals-acadmedsg.2021154.
No abstract available

Publication types

  • Letter

MeSH terms

  • Biomarkers / blood
  • COVID-19* / diagnosis
  • Chemokine CXCL10* / blood
  • Humans
  • Lung Diseases* / diagnosis
  • Lung Diseases* / virology
  • Severity of Illness Index

Substances

  • Biomarkers
  • CXCL10 protein, human
  • Chemokine CXCL10